PL103798B1 - Sposob wytwarzania nowych pochodnych chinazoliny - Google Patents

Sposob wytwarzania nowych pochodnych chinazoliny Download PDF

Info

Publication number
PL103798B1
PL103798B1 PL1975193419A PL19341975A PL103798B1 PL 103798 B1 PL103798 B1 PL 103798B1 PL 1975193419 A PL1975193419 A PL 1975193419A PL 19341975 A PL19341975 A PL 19341975A PL 103798 B1 PL103798 B1 PL 103798B1
Authority
PL
Poland
Prior art keywords
formula
group
lower alkyl
chinazoline
alk
Prior art date
Application number
PL1975193419A
Other languages
English (en)
Other versions
PL193419A1 (pl
Original Assignee
Pfizer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corporation filed Critical Pfizer Corporation
Publication of PL193419A1 publication Critical patent/PL193419A1/pl
Publication of PL103798B1 publication Critical patent/PL103798B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

1. Zastrzezenie patentowe Sposób wytwarzania nowych pochodnych china- zoliny o ogólnym wzorze 1, w którym R2 oznacza 30 atom wodoru lub nizsza grupe alkilowa, X ozna¬ cza grupe -CH =CH-, Y znajduje sie w pozycji 3 lub 4 pierscienia C i oznacza grupe o wzorze -CH2COR3, w którym R3 oznacza nizszy rodnik alkilowy lub alkoksylowy, albo Y oznacza grupe 35 o wzorze -CH2CONR6R7 lub -CH2CSNR6R7, w któ¬ rych to wzorach R6 i R7 oznaczaja atomy wodoru lub nizsze rodniki alkilowe, znamienny tym, ze pochodna chinazoliny o ogólnym wzorze 2, w któ¬ rym R2 ma wyzej podane znaczenie, Z oznacza 40 grupe -/CH2/2- lub -/CH2/3-, poddaje sie reakcji z fosfonianem o wzorze 3 lub 4, w których to wzorach Y ma wyzej podane znaczenie, Alk ozna¬ cza nizszy rodnik alkoksylowy, a Ar oznacza niz¬ szy rodnik aryloksylowy, po czym otrzymany zwia- 45 ' zek o wzorze 1 ewentualnie przeprowadza sie zna¬ nym sposobem w addycyjna sól z farmakologicz¬ nie dopuszczalnym kwasem.103 798 &v R20 ^ H wzór 1 6 (Alk). PY II O h/ZOT 3 I (Ar), PY O \ / CR pierscien U II CHX wzór 6 HXO HxCO + C2H60^CHW CH7C0CH CHCOCH: Schemat PL
PL1975193419A 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny PL103798B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25

Publications (2)

Publication Number Publication Date
PL193419A1 PL193419A1 (pl) 1978-04-24
PL103798B1 true PL103798B1 (pl) 1979-07-31

Family

ID=10344259

Family Applications (6)

Application Number Title Priority Date Filing Date
PL1975193421A PL103791B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975182162A PL99427B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975193422A PL104615B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975193423A PL103797B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975193419A PL103798B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975193420A PL103789B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny

Family Applications Before (4)

Application Number Title Priority Date Filing Date
PL1975193421A PL103791B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975182162A PL99427B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975193422A PL104615B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny
PL1975193423A PL103797B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1975193420A PL103789B1 (pl) 1974-07-25 1975-07-18 Sposob wytwarzania nowych pochodnych chinazoliny

Country Status (7)

Country Link
AT (1) AT344178B (pl)
BE (1) BE831654A (pl)
CS (1) CS192549B2 (pl)
ES (4) ES439690A1 (pl)
HU (1) HU174961B (pl)
PL (6) PL103791B1 (pl)
SU (5) SU578874A3 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070004763A1 (en) * 2005-06-10 2007-01-04 Nand Baindur Aminoquinoline and aminoquinazoline kinase modulators

Also Published As

Publication number Publication date
PL193420A1 (pl) 1978-04-24
ES439690A1 (es) 1977-07-01
PL193423A1 (pl) 1978-04-24
SU625606A3 (ru) 1978-09-25
ES455986A1 (es) 1978-06-01
PL193422A1 (pl) 1978-06-05
ES455985A1 (es) 1978-06-16
PL104615B1 (pl) 1979-08-31
PL193419A1 (pl) 1978-04-24
SU578874A3 (ru) 1977-10-30
SU634671A3 (ru) 1978-11-25
PL103791B1 (pl) 1979-07-31
PL193421A1 (pl) 1978-04-24
AT344178B (de) 1978-07-10
PL99427B1 (pl) 1978-07-31
ES455984A1 (es) 1978-06-01
PL103789B1 (pl) 1979-07-31
BE831654A (fr) 1976-01-23
CS192549B2 (en) 1979-08-31
SU613723A3 (ru) 1978-06-30
PL103797B1 (pl) 1979-07-31
HU174961B (hu) 1980-04-28
SU858563A3 (ru) 1981-08-23
ATA525275A (de) 1977-11-15

Similar Documents

Publication Publication Date Title
ATE19513T1 (de) Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
IE46278L (en) Tri-phenyl-substituted-piperazine derivatives
PL113054B1 (en) Method of guanidine derivatives preparation
HU896028D0 (en) Xanthone derivatives and process for the preparation thereof
PT65019B (de) Phenylalkancarbonsaure-derivate und verfahren zu ihrer herstellung
IE45700L (en) PYRAZOLO (3,4-b) PYRIDINES
ES440760A1 (es) Procedimiento para preparar derivados de quinoxalina y qui- nazolina.
ES8801819A1 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
PL103798B1 (pl) Sposob wytwarzania nowych pochodnych chinazoliny
ES8700857A1 (es) Un procedimiento para la produccion de dihidropiridinas
ES443912A1 (es) Procedimiento para preparar derivados del acido fenil-aceti-co.
YU46703B (sh) Postupak za dobijanje hinolinskih derivata
NO934227L (no) Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
ZA81863B (en) 5,6; 8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives, the preparation thereof and compositions
PL58473B1 (pl)
ATE38380T1 (de) Bisamidindiphenylderivate, ein verfahren zu ihrer herstellung und ihre verwendung als chemotherapeutika.
JPS5535100A (en) Clavuranic acid derivative*its composition and manufacture
ES327761A1 (es) Procedimiento para la preparacion de nuevos derivados de azepina.
TH808EX (th) อนุพันธ์ของอินโดลิซีนใหม่ และกรรมวิธีในการเตรียมอนุพันธ์นี้
PL90605B1 (pl)
ES428638A1 (es) Procedimiento para la preparacion de derivados del acido 7- acilamido-3-cefem-4-carboxilico.
ES8203880A1 (es) Un procedimiento para preparar una 4,5-dihidro-2-r-4-r -6-py-3(2h)-piridazinona